Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry W Herr

Showing results (181-190 of 230) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCCWassim Kassouf, Piyush K Agarwal, Harry W Herr, et al.
European Urology|August 5, 2008
Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodologyAhmad Shabsigh, Ruslan Korets, Kinjal C Vora, et al.
The Journal of Urology|September 27, 2012
Urinary diversion practice patterns among certifying American urologistsJonathan L Silberstein, Stephen A Poon, Alexandra C Maschino, et al.
The Journal of Urology|March 20, 2010
Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancerDavid S Yee, Shahrokh F Shariat, William T Lowrance, et al.
International Journal of Radiation Oncology, Biology, Physics|March 30, 2016
Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder CancerBrian C Baumann, Jiwei He, Wei-Ting Hwang, et al.
BJU International|April 27, 2020
Primary urethral cancer: treatment patterns and associated outcomesRoy Mano, Emily A Vertosick, Joseph Sarcona, et al.
European Urology|March 12, 2014
Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic reviewGuillaume Ploussard, Siamak Daneshmand, Jason A Efstathiou, et al.
The Journal of Urology|November 13, 2004
Bladder cancer as a prognostic factor for upper tract transitional cell carcinomaMichael Mullerad, Paul Russo, Dragan Golijanin, et al.
Bladder Cancer (Amsterdam, Netherlands)|May 19, 2017
Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma <i>In Situ</i> of the Bladder who failed Bacillus Calmette Guerin (NCT01259063)Guido Dalbagni, Nicole Benfante, Daniel D Sjoberg, et al.
The Journal of Urology|January 10, 2004
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II studyBadrinath R Konety, James A Eastham, Vicor E Reuter, et al.
Pageof 23

Showing results (181-190 of 230) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCCWassim Kassouf, Piyush K Agarwal, Harry W Herr, et al.
European Urology|August 5, 2008
Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodologyAhmad Shabsigh, Ruslan Korets, Kinjal C Vora, et al.
The Journal of Urology|September 27, 2012
Urinary diversion practice patterns among certifying American urologistsJonathan L Silberstein, Stephen A Poon, Alexandra C Maschino, et al.
The Journal of Urology|March 20, 2010
Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancerDavid S Yee, Shahrokh F Shariat, William T Lowrance, et al.
International Journal of Radiation Oncology, Biology, Physics|March 30, 2016
Validating a Local Failure Risk Stratification for Use in Prospective Studies of Adjuvant Radiation Therapy for Bladder CancerBrian C Baumann, Jiwei He, Wei-Ting Hwang, et al.
BJU International|April 27, 2020
Primary urethral cancer: treatment patterns and associated outcomesRoy Mano, Emily A Vertosick, Joseph Sarcona, et al.
European Urology|March 12, 2014
Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic reviewGuillaume Ploussard, Siamak Daneshmand, Jason A Efstathiou, et al.
The Journal of Urology|November 13, 2004
Bladder cancer as a prognostic factor for upper tract transitional cell carcinomaMichael Mullerad, Paul Russo, Dragan Golijanin, et al.
Bladder Cancer (Amsterdam, Netherlands)|May 19, 2017
Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma <i>In Situ</i> of the Bladder who failed Bacillus Calmette Guerin (NCT01259063)Guido Dalbagni, Nicole Benfante, Daniel D Sjoberg, et al.
The Journal of Urology|January 10, 2004
Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II studyBadrinath R Konety, James A Eastham, Vicor E Reuter, et al.
Pageof 23